FierceBiotech ٢٣ أبريل ٢٠٢٦ Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec
FierceBiotech ٢٣ أبريل ٢٠٢٦ From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree
FierceBiotech ٢٢ أبريل ٢٠٢٦ Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
FierceBiotech ٢٠ أبريل ٢٠٢٦ AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs
FierceBiotech ٩ أبريل ٢٠٢٦ Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders
FierceBiotech ٢٠ مارس ٢٠٢٦ Genentech antibody fails to boost muscle in rare diseases, raising questions for obesity trial
FierceBiotech ١٠ مارس ٢٠٢٦ Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
FierceBiotech ٩ مارس ٢٠٢٦ Roche's oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits
FierceBiotech ٦ مارس ٢٠٢٦ Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
FierceBiotech ٤ مارس ٢٠٢٦ Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
FierceBiotech ٦ فبراير ٢٠٢٦ Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals
FierceBiotech ٢٩ يناير ٢٠٢٦ Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
FierceBiotech ٩ يناير ٢٠٢٦ Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech ١٠ ديسمبر ٢٠٢٥ Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial
FierceBiotech ٤ ديسمبر ٢٠٢٥ Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron